Cortexyme Alzheimer’s Study Fails; Drug Slows Cognitive Decline In Some Patients

Subpopulation Efficacy Limited To One Of Two Primary Endpoints

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.